MedTrace Logo

Confirmatory Study of OPC-12759 Ophthalmic Suspension

NCT00885079 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2013-12-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to verify whether OPC-12759 ophthalmic suspension is effective compared with active control in dry eye patients.

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

OPC-12759 Ophthalmic suspension

OPC-12759 Ophthalmic suspension 2%

DRUG

Hyalein Mini Ophthalmic solution

Hyalein Mini Ophthalmic solution 0.1%

Sponsors & Collaborators

  • Otsuka Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Eiji Murakami · OPCJ-DDO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-03-31
Completion
2010-04-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00885079 on ClinicalTrials.gov